Stock ALOPM ONCODESIGN PRECISION MEDICINE
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Oncodesign Precision Medicine

Equities

ALOPM

FR001400CM63

Market Closed - Euronext Paris
Other stock markets
 06:51:03 21/06/2024 pm IST 		5-day change 1st Jan Change
1.05 EUR 0.00% Intraday chart for Oncodesign Precision Medicine -4.55% -41.99%
15/05 Oncodesign Precision Medicine and Navigo Proteins GmbH Sign A Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents CI
25/01 Oncodesign Precision Medicine: fundraising on the horizon CF

Evolution of the average Target Price on Oncodesign Precision Medicine

Price target over the last 5 years

History of analyst recommendation changes

c165f8f8e61d3f2701ddf918a.mHAbUI4511JpmueBEXuDWYCHwraOmFHRo7e2AL3AA50.0UJyJcdhnmsjwK3OfELyEcfMoN_RwgOi0fDESf6Ucs7xFiMf63q7Nxjr1w~a9e4996913c62191c14a704c84b130e5

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.05 EUR
Average target price
2.48 EUR
Spread / Average Target
+136.19%
High Price Target
2.66 EUR
Spread / Highest target
+153.33%
Low Price Target
2.3 EUR
Spread / Lowest Target
+119.05%

Consensus detail

Consensus revision (last 18 months)

Ratings for Oncodesign Precision Medicine

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALOPM Stock
  4. Consensus Oncodesign Precision Medicine